Renaud Ronald C JR
- SEC CIK
- 0001354434
No open-market purchases or sales filed in the past year.
Current role at each company
- UPB Upstream Bio, Inc.Directoras of Jun 11, 2026
- KLRA Kailera Therapeutics, Inc.CEO & Presidentas of Jun 11, 2026
- CERE Cerevel Therapeutics Holdings, Inc.President & CEOas of Aug 5, 2024
- ATRA Atara Biotherapeutics, Inc.Directoras of Jun 27, 2022
- IMA ImageneBio, Inc.Directoras of Jun 13, 2022
Show 1 more company
- Translate Bio, Inc.Chief Executive Officeras of Sep 14, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Renaud Ronald C JR as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CERE Cerevel Therapeutics Holdings, Inc.
President & CEO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2023 (view filing) | Aug 3 | 4 days | Renaud Ronald C JRPresident & CEO | PPurchase | +83.9K | $23.96 | +$2.01M | New position83.9K after |
Translate Bio, Inc.
Chief Executive Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2021 (view filing) | Sep 14 | Same day | Renaud Ronald C JRChief Executive Officer | SSale | −503.2K | $38.00 | −$19.1M | −100.0%0 after | |
| Sep 14, 2021 (view filing) | Sep 14 | Same day | Renaud Ronald C JRChief Executive Officer | SSale | −450.8K | $38.00 | −$17.1M | −100.0%0 after | 2 lots |
| Sep 14, 2021 (view filing) | Sep 14 | Same day | Renaud Ronald C JRChief Executive Officer | SSale | −2.51M | $0.00 | $0 | –0 after | Derivative5 lots |